FDA grants accelerated approval to infigratinib for metastatic cholangiocarcinoma

Hematology / Oncology

Source: FDA Center for Drug Evaluation and Research - What's New - May 28, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news